Cite
HARVARD Citation
Rabinovich‐Guilatt, L. et al. (n.d.). Impact of dosing regimen of custirsen, an antisense oligonucleotide, on safety, tolerability and cardiac repolarization in healthy subjects. British journal of clinical pharmacology. pp. 436-445. [Online].